Applied Molecular Transport to Present at JMP Securities Life Sciences Conference
Applied Molecular Transport Inc. (AMTI) announced that its CEO, Dr. Tahir Mahmood, will participate in a fireside chat at the JMP Securities Life Sciences Conference on June 17, 2021, at 2:00 p.m. ET. The event will be available via live webcast on the company's website, with an archived replay accessible for 30 days post-event. AMTI focuses on developing novel oral biologic product candidates to treat various diseases, leveraging its proprietary technology to facilitate active transport across the intestinal barrier.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the JMP Securities Life Sciences Conference on Thursday, June 17, 2021 at 2:00 p.m. ET.
A live webcast will be accessible via the Events page of the Applied Molecular Transport website at https://ir.appliedmt.com/news-events/events. An archived replay will be available for 30 days following the event.
About Applied Molecular Transport Inc.
Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. AMT’s proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of diverse therapeutic modalities across the intestinal epithelial (IE) barrier. Active transport is an efficient mechanism that uses the cell’s own machinery to transport materials across the IE barrier. AMT believes that its ability to exploit this mechanism is a key differentiator of its approach. AMT is developing additional oral biologic product candidates in patient-friendly oral forms that are designed to either target local gastrointestinal tissue or enter systemic circulation to precisely address the relevant biology of a disease.
AMT’s headquarters, internal GMP manufacturing and lab facilities are located in South San Francisco, CA. For additional information on AMT, please visit www.appliedmt.com.
Investor Relations Contact:
Andrew Chang
Head, Investor Relations & Corporate Communications
achang@appliedmt.com
Media Contacts:
Alexandra Santos
Wheelhouse Life Science Advisors
asantos@wheelhouselsa.com
Aljanae Reynolds
Wheelhouse Life Science Advisors
areynolds@wheelhouselsa.com
FAQ
When will AMTI's CEO participate in the JMP Securities Life Sciences Conference?
How can I watch the AMTI fireside chat at the conference?
What is the focus of Applied Molecular Transport Inc.?
Where is the headquarters of Applied Molecular Transport located?
What technology does AMTI use for its product development?
